Diverse Nucleic Acid Modification Using Sulfinate Chemistry

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for chemically modifying nucleic acids, such as RNA, are limited in diversity and efficiency, particularly in increasing stability and functionalization for therapeutic applications, leading to high synthesis costs and limited insight into RNA structure.

Innovation Solution

The use of sulfinate chemistry to modify the Hoogsteen edge of nucleobases in nucleic acids, allowing for the addition of diverse functional groups and improved stability against nucleases, as well as efficient transfection and fluorophore attachment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If traditional chemical modification methods are used for nucleic acids, then modification can be achieved, but the diversity and efficiency of modifications are limited and synthesis costs are high

Engineering Contradiction:
Improvemodification diversityVSAvoidsynthesis cost
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent changes the chemical parameters by using sulfinate salts as reagents instead of traditional modification methods. This parameter change enables diverse functional groups to be introduced at C-H positions of heteroarenes, achieving high modification diversity while maintaining cost-effectiveness through a unified reaction platform

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The sulfinate salt modification method serves multiple functions: it can introduce various functional groups (R groups), modify different types of heteroarenes, and apply to diverse nucleic acid structures. This universal approach replaces multiple specialized modification methods, reducing overall synthesis costs while expanding modification diversity

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If RNA is used as a therapeutic, then therapeutic potential is achieved, but in vivo stability is poor due to nuclease degradation

Engineering Contradiction:
Improvein vivo stabilityVSAvoidhalf-life
Core Design Contradiction:
ReliabilityVSDuration of action of stationary object

Solution Approach 1:

The patent uses sulfinate salt modification to introduce functional groups that protect RNA from nuclease degradation. The modification converts the vulnerability of RNA to enzymatic attack into an opportunity for enhanced stability, as the modified C-H positions create steric and electronic barriers against nuclease access

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The modification targets specific C-H positions on heteroarene rings of nucleobases, creating localized protective groups at strategic positions. This local modification approach preserves the overall RNA structure and function while providing targeted protection against degradation at critical sites

Inventive Principle:
Principle #3Local quality

3Device complexity

If chemical modification methods are limited, then synthesis is simpler, but functional groups that could increase stability and functionality cannot be added

Engineering Contradiction:
Improvesynthesis complexityVSAvoidfunctional group diversity
Core Design Contradiction:
Device complexityVSAdaptability or versatility

Solution Approach 1:

The patent changes the chemical parameters by using sulfinate salts with variable R groups, enabling a wide range of functional groups to be introduced through a single modification platform. This parameter variability allows diverse functionality to be achieved without proportionally increasing synthesis complexity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The sulfinate salt acts as an intermediary reagent that facilitates the introduction of diverse functional groups. This intermediary approach simplifies the overall synthesis by providing a unified mechanism for adding different R groups, rather than requiring separate complex synthesis pathways for each functional group

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables flexible and cost-effective chemical modification of nucleic acids, enhancing stability, transfection efficiency, and structural insight, overcoming limitations of existing methods.

Implementation Method 1

contacting the nucleic acid molecule with a sulfinate salt that includes an R functional group in the presence of a radical initiator under conditions sufficient to add the R functional group on a C—H group of the heteroarene

Methodology Applied
Scientific EffectRadical chemistry:

Implementation Method 2

monitoring degradation of the modified nucleic acid molecule over time in the presence of a nuclease, wherein decreased degradation in the presence of the nuclease is indicative of an R functional group that stabilizes the nucleic acid molecule

Methodology Applied
Scientific EffectNuclease resistance:

Data Source

PatentUS12421266B2Diverse and flexible chemical modification of nucleic acids
Publication Date: 2025.09.23 RGT UNIV OF CALIFORNIA
  • US12421266B2 patent drawing
  • US12421266B2 patent drawing
  • US12421266B2 patent drawing

AI summary

The present invention provides a method for chemically modifying a nucleic acid molecule using sulfinate reagents to increase stability in vitro and in vivo. Screening methods for nucleobase modifications that reduce cleavage of a nucleic acid molecule by a nuclease are also provided.